palmitoylethanolamide.com.au
HomeResearchZimmermann 2019

Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses

Zimmermann T, Bartsch JC, Beer A, Lomazzo E, Guggenhuber S, Lange MD, Bindila L, Pape HC, Lutz B. Neuropsychopharmacology. 2019 Jul;44(8):1377-1388.

Laboratory studyOther animals

Design
Laboratory study
Subjects
Adult mice with FAAH selectively overexpressed in hippocampal CA1-CA3 glutamatergic neurons, using a Cre/loxP and AAV delivery system
Dose used in the study
Not applicable; this study manipulated the enzyme (FAAH) that breaks down PEA and anandamide, rather than administering PEA
Duration
Not stated in the abstract
What was measured
Hippocampal FAAH activity; anandamide, PEA, 2-AG and OEA levels; synaptic activity and long-term potentiation/depression by electrophysiology; anxiety-like behaviour, object recognition memory and fear extinction

What the authors reported

FAAH overexpression raised its enzymatic activity and lowered hippocampal anandamide and PEA (2-AG and OEA unchanged). This increased excitatory and inhibitory synaptic activity and long-term potentiation, without changing long-term depression or short-term plasticity. Behaviourally, it raised anxiety-like behaviour and impaired object recognition memory and fear-memory extinction.

Limits of this study

A genetically modified mouse model; it cannot show effect in people. Funding and conflicts not stated in the abstract.

Source

PubMed 30532004 · doi:10.1038/s41386-018-0274-7

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.